Summary
| Direction in Long COVID | ↑ Elevated — higher than in the comparison group |
|---|---|
| Category | Proteomic |
| Also described as | Factor X, thrombin, etc. |
| Compared against | HC (healthy controls) |
| Associated symptoms | Thromboinflammation |
| Test type | Blood test (serum / plasma / whole blood) |
| Source | Baalbaki et al. 2025 — doi:10.1111/all.16526 |
| Condition atlas | Long COVID Biomarker Atlas |
Trials, interventions and tests
In clinical-trial registrations this marker maps to the outcome term To compare alterations in thromboinflammatory components (prothrombin time (PT)), among the three treatment arms. (2 registered trials use a matching outcome measure).
Clinical trials using Coagulation cascade proteins as an outcome
- NCT06766825: Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC) (Recruiting)
Outcome measure: To compare alterations in thromboinflammatory components (prothrombin time (PT)), among the three treatment arms. - NCT05669261: Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection (Unknown)
Outcome measure: Assessment of Change in Prothrombin time/partial thromboplastin time (PT/PTT Coagulation factors II) Laboratory Testing Results
Related Proteomic markers in Long COVID
Full list: Long COVID Biomarker Atlas.
Frequently asked questions
Is Coagulation cascade proteins high or low in Long COVID?
Elevated. Studies summarised in the OSMF atlas report higher Coagulation cascade proteins in Long COVID than in healthy controls. Source: Baalbaki et al. 2025.
What symptoms is Coagulation cascade proteins associated with in Long COVID?
The cited literature associates this marker with Thromboinflammation. These are population-level associations and do not mean the marker causes the symptoms.
Which test measures Coagulation cascade proteins?
It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.
Is one abnormal Coagulation cascade proteins result diagnostic of Long COVID?
No. No single biomarker is diagnostic of Long COVID. Coagulation cascade proteins findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.